• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»BioEvents»Event Report – SelectBio’s Biomarkers and Antibody Drug Conjugates

Event Report – SelectBio’s Biomarkers and Antibody Drug Conjugates

0
By Biotech Express on June 12, 2018 BioEvents, Biotech News

Two International Conferences “Biomarkers- From Research to Commercialization” and “Antibody Drug Conjugates” were organized on May 24- 25, 2018 in Hotel Le Meridian Bangalore, Bengaluru in which about 75 Scientists from India and abroad participated. These two day events witnessed above 30 enlightening invited talks, 7 oral presentations, 4 company presentations and an exhibition featuring technology giants like Agilent, Sartorius, GeNext Genomics and Krishgen Biosystems.

During his welcome address, Dr Sanjay Bajaj, Managing Director, Select Biosciences India Pvt. Ltd. greeted
all the speakers, delegates and exhibitors and introduced the organization and its activities to the audience.
This was followed by speaker introduction session in which each of the speakers introduced themselves to theaudience and shared their research interests. This brief introduction helped the audience to instantly connect and initiate networking with the speakers. In this session, mementos were also presented to the speakers and exhibitors. This was followed by business networking session during which participants exchanged cards with experts and other delegates. A group photograph was also organized as a part of the meeting.

Biomarkers- From Research to Commercialization
In “Biomarkers-From Research to Commercialization” conference, many renowned speakers discussed about topics such as Biomarkers for Diagnostics, Cancer Biomarkers, Extracellular Biomarkers, Biomarkers for Clinical Applications, Biosensors, Biodetection, Probes and Imaging Techniques. Many young researchers and faculties also presented their research work in the form of Oral and Poster Presentations which was appreciated by all. In the first scientific session entitled “Biomarkers for Diagnosis” Dr Utpal Tatu, Professor, IISc, Bangalore, delivered Keynote Address in which he discussed how novel prognostic and predictive biomarkers are discovered from biological fluids using analytical techniques such as Mass Spectrometry. Next talk was delivered by, Dr Harshini Mukundan, Principal Investigator, Los Alamos National Laboratory, USA who deliberated on development of universal diagnostics for bacterial infections by employing engineering solutions and ultra-sensitive sensors, comprehensing host-pathogen biology, designing tailored assay formats and extensive clinical validation.

The session entitled “Cancer Biomarkers” focused on discovery and development of novel biomarkers in metastatic uveal melanoma tumors and breast cancer. Dr Yogeshwer Shukla from CSIR-IITR, contemplated on role of proteomics for breast cancer classification by careful identification of protein signature in blood plasma and tissue samples. Amongst other talks, Dr Aditi Bhattacharya delivered a talk which focused on diseases of intellectual disability and autism, Fragile X Syndrome. She presented the data derived from proteomic analysis of intact brain tissue and identified proteins derived from blood which act as molecular barcodes for Fragile X Syndrome.

On Day 2, Dr Youhe Gao from Beijing Normal University, China addressed the audience on how early stage identification of biomarkers from Urine source aids in treatment of various diseases including lung fibrosis, liver fibrosis, diabetes, chornic pancreatitis, chronic obstractive pulmonary disease, bacterial meningitis and many more, in the session entitled “Biomarkers for Diseases and Clinical Applications”. Dr Michael Lutz, CEO, LifeCodexx, Germany presented data on a newly developed NIPT assay based on quantitative real-time PCR i.e. qNIPT technology for the determination of fetal trisomy.

Antibody Drug Conjugates

The “Antibody Drug Conjugates” Conference was initiated with scientific sessions on Antibody Engineering followed by topics namely ADC Development, ADC Analysis, Clinical Applications of ADC. The Key Speakers in this meeting were Dr Amy Han, Regeneron Pharmaceuticals; Dr Dimiter Dimitrov, University of Pittsburgh; Dr Jagdish Nigade, Roche; Dr Rajan Dighe, Indian Institute of Science; Dr Nitin Damle, SPARC; Dr Satish Singh, Lonza; Dr Ashvini Kumar Dubey, Zumutor Biologics and Dr Priyaranjan Pattanaik, Syngene. An interactive session was also held on second day of the meeting in which the attendees put up questions to the experts. This Session was highly appreciated by all the participants because many of their queries were answered and therefore everyone enjoyed it.

The First Scientific session on “Antibody Engineering” witnessed 5 exciting talks from organizations namely Mazumdar Shaw Center for Translational Research (MSCTR), Indian Institute of Science (IISc), Zumutor Biologics, AbGenics LifeSciences and IPCA Laboratories. Dr Rajan Dighe, Professor, IISc, Bengaluru delivered Keynote Presentation in which he highlighted on cancer immunotherapy against Notch family of receptors. He discussed how his group generated, characterized and evaluated the effect of humanized monocloncal antibodies (MAbs) and Single Chain fragment variables (ScFvs) in the inhibition of ovarian cancer cells and how the research work has been translated to development of novel tools and strategies.

In the session on “ADC Development”, Dr Amy Han, Director, Chemistry, Regeneron Pharmaceuticals, USA highlighted conjugation of Glucocorticoid steroids (GC steroids) with antibody using site directed conjugation and novel linker chemistries. This was done to enable specific delivery of steroids to diseased tissue cells of interest. Dr Han presented her data on how their lead steroid-ADCs demonstrated favorable pharmacokinetics with limited targeted mediated clearance in humanized mice. She informed that the treatment of the mice with these, prevented TNFα release from peritoneal macrophages that were challenged with LPS ex vivo. Another interesting talk was delivered by Dr Dimiter Stanchev Dimitrov, Professor, University of Pittsburgh, USA on promising anti-cancer therapy which targeted the tumor vasculature with ADCs. Dr Dimiter demonstrated an ADCMMAE targeting CD276 destroyed CD276-positive cancer cells, but was ineffective against tumor vasculature. In contrast he mentioned that pyrrolobenzodiazepine- conjugated CD276-ADC killed both cancer cells and tumor vasculature, eradicating large established tumors and metastases, and improving long-term overall survival. Thus, he stressed that CD276 targeted dual-compartment ablation could aid in development of highly selective broad-acting anti-cancer therapies.

The second day of “Antibody Drug Conjugates” meeting included a combination of scientific and technical sessions. In one of an exhilarating session on “Overcoming Challenges in Development of Successful ADCs” which involved 3 thrilling presentations. The first Keynote Presentation by Dr Nitin Damle, Senior Vice President and Head, Discovery Biology/CSO, Sun Pharma Advanced Research Company Limited, India was on translation of pre-clinical data into clinical success in cancer therapy and immunotherapy. He highlighted various challenges faced by researchers and deliberated on possible solutions for clinical success. Another Talk in this session delivered by Dr Jagdish Nigade, Group Medical Manager, Roche, India focused on various aspects related to clinical studies of Trastuzumab emtansine (T-DM1) for HER2 Positive Breast Cancer. The last but not the least talk by Dr Satish Singh, Lonza, Switzerland provided an overview of design aspects of ADCs and the resultant impact on CMC development. The design of ADC has a significant impact on PK/PD, toxicity, physico-chemical properties and manufacturing of ADCs involves facilities with the capability to handle high potency materials.

Based upon the feedback received from the participants, it was concluded that overall the conference was very good in terms of scientific contents, quality of talks and networking opportunity. The event concluded with the closing remarks and vote of thanks by Dr Sanjay Bajaj.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

BioAsia 2023 to be held in February 24-26 in Telangana, India

Praj Industries and ESIIC partner to further bioeconomy in Egypt

Event: Australia’s biggest week in biotech kicks off in Perth

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.